Skip to main content
TipRanks
Go Ultimate75% OFF

PuraPharm Corp. Ltd. (1498) Financial Statements

1 Followers

PuraPharm Corp. Ltd. Financial Overview

PuraPharm Corp. Ltd.'s market cap is currently HK$117.69M. The company's EPS TTM is HK$-0.06; its P/E ratio is -3.87; and it has a dividend yield of 0.48%. PuraPharm Corp. Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueHK$ 336.11MHK$ 382.09MHK$ 406.86MHK$ 448.07MHK$ 659.59M
Gross ProfitHK$ 180.16MHK$ 205.14MHK$ 216.63MHK$ 260.59MHK$ 421.85M
Operating IncomeHK$ -29.98MHK$ -29.41MHK$ -51.58MHK$ -64.50MHK$ 17.62M
EBITDAHK$ 28.30MHK$ 36.42MHK$ -26.31MHK$ -46.34MHK$ -40.03M
Net IncomeHK$ -35.22MHK$ -35.44MHK$ -106.08MHK$ -120.21MHK$ -121.88M
Balance Sheet
Cash & Short-Term InvestmentsHK$ 21.18MHK$ 12.79MHK$ 47.22MHK$ 91.36MHK$ 85.05M
Total AssetsHK$ 693.76MHK$ 715.73MHK$ 843.96MHK$ 1.02BHK$ 1.21B
Total DebtHK$ 351.14MHK$ 363.76MHK$ 424.77MHK$ 503.16MHK$ 531.96M
Net DebtHK$ 329.97MHK$ 350.96MHK$ 404.64MHK$ 396.14MHK$ 446.90M
Total LiabilitiesHK$ 560.59MHK$ 604.53MHK$ 690.73MHK$ 757.18MHK$ 803.13M
Stockholders' EquityHK$ 130.48MHK$ 111.20MHK$ 153.24MHK$ 258.29MHK$ 401.56M
Cash Flow
Free Cash FlowHK$ 25.69MHK$ 89.18MHK$ 57.95MHK$ 42.29MHK$ -45.89M
Operating Cash FlowHK$ 28.52MHK$ 103.98MHK$ 79.61MHK$ 65.85MHK$ -14.52M
Investing Cash FlowHK$ 24.12MHK$ -11.71MHK$ -18.20MHK$ -25.45MHK$ 6.00M
Financing Cash FlowHK$ -46.34MHK$ -86.43MHK$ -122.39MHK$ -12.94MHK$ -13.87M

Currency in HKD

PuraPharm Corp. Ltd. Earnings and Revenue History

-400M0400M800M-40 %-20 %0 %20 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

PuraPharm Corp. Ltd. Liabilities to Assets

0500M1B1.5B45 %60 %75 %90 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

PuraPharm Corp. Ltd. Cash Flow

-400M-300M-200M-100M0100M200M300M201720182019202020212022202320242025OperatingInvestingFinancing

PuraPharm Corp. Ltd. Forecast EPS vs Actual EPS

-0.10000Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss